Mercurna has reached its scientific and IP milestones of the RedMedtech Discovery Fund II (RMDFII) by providing exciting data (in vitro and in vivo) on mCura1, Mercurna’s lead formulation for chronic kidney disease.
ShanX Medtech is delighted to have been named one of Hello Tomorrow’s Deep Tech Pioneers! Being a Deep Tech Pioneer means that they have been recognised by Hello Tomorrow as 𝘰𝘯𝘦 𝘰𝘧 𝘵𝘩𝘦 𝘮𝘰𝘴𝘵 𝘱𝘳𝘰𝘮𝘪𝘴𝘪𝘯𝘨 𝘱𝘳𝘰𝘫𝘦𝘤𝘵𝘴 𝘪𝘯 𝘥𝘦𝘦𝘱 𝘵𝘦𝘤𝘩 𝘵𝘰 𝘥𝘢𝘵𝘦.
Last week, the Venture Challenge Fall 2021 kicked off with innovative Life Sciences & Health startups participating in the first bootcamp. The participating teams worked on shaping their value propositions, vision and competitive differentiation to translate their idea into a solid business case.
Friday September 10 the first in-person LS@W Expert Class of 2021 took place. Topic of this session was how to design your clinical study in which experts shared their hands-on experience with an audience of Biotech and Medtech startups.
Sirius Medical, a medical device innovator developing the next generation of tumor localization technology, is pleased to announce today that RMS Medical Devices will be commercial partner in Belgium and Luxemburg for Sirius Pintuition.